Hellstein, John W <br/><br/>
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs.  [electronic resource] 

 -  Journal of the American Dental Association (1939)  Nov 2011 
 - 1243-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1943-4723 
<br/><br/><label>Standard No.: </label>10.14219/jada.archive.2011.0108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Biomarkers--blood<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--prevention & control<br/>Bone Density Conservation Agents--adverse effects<br/>Collagen Type I--blood<br/>Denosumab<br/>Dental Care for Chronically Ill<br/>Diphosphonates--adverse effects<br/>Humans<br/>Oral Hygiene<br/>Oral Surgical Procedures<br/>Osteoporosis--drug therapy<br/>Patient Care Planning<br/>Peptides--blood<br/>RANK Ligand--antagonists & inhibitors<br/>Risk Factors